GLP-1 drugs, e.g., Wegovy and Ozempic, were originally developed for diabetes management, but they are now being taken for weight control. While they are not currently covered by most insurers, the insurance industry opinion is that they likely will be covered within a year or so because they have a beneficial effect on employees’ health, thereby reducing other potential costs. Stay tuned…
GLP-1 Drugs – to Cover or Not to Cover
Previous
Previous
Room for Improvement in Communicating Employee Benefits
Next
Next
